Literature DB >> 16905984

Lymphovascular invasion as a prognostic tool for advanced bladder cancer.

Ferran Algaba1.   

Abstract

PURPOSE OF REVIEW: Lymphovascular invasion has been correlated with the metastatic ability of the cancer. It has been studied in urological tumours at every location, but it has only been included as a prognostic factor in the TNM (tumour, lymph nodes and metastasis) classification of germ cell testicular tumours. The purpose of this evaluation is to look into the predictive value of lymphovascular invasion in locally advanced bladder cancer. RECENT
FINDINGS: Studies carried out in patients who underwent cystectomy report a lymphovascular invasion incidence of 30-50% of the cases. All of them agree that there is a correlation between the presence of lymphovascular invasion and disease evolution, but some authors consider that only blood vessel invasion is a statistically significant independent prognostic factor, and others find that this happens only in lymph node-negative cases.
SUMMARY: All papers stress the prognostic value of lymphovascular invasion, most of them as an independent factor, but there are still some doubts as to its use in clinical decision making, owing to the poor diagnosis reproducibility. This is why it would be necessary to reach a consensus on strict diagnostic criteria as soon as possible to be able to incorporate this prognostic factor in clinical practice.

Entities:  

Mesh:

Year:  2006        PMID: 16905984     DOI: 10.1097/01.mou.0000240311.08701.55

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  12 in total

1.  [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Authors:  T Martini; P Ströbel; A Steidler; N Petrakopoulou; P Erben; C Bolenz
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

Review 2.  The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.

Authors:  Romain Mathieu; Ilaria Lucca; Morgan Rouprêt; Alberto Briganti; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

3.  Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.

Authors:  Yuan-Feng Tian; Hui Zhou; Gan Yu; Ji Wang; Heng Li; Ding Xia; Hai-Bing Xiao; Ji-Hong Liu; Zhang-Qun Ye; Hua Xu; Qian-Yuan Zhuang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 4.  Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Authors:  Sandip M Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2011-10-11       Impact factor: 14.432

5.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Authors:  Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark Smolkin; Garret Hampton; Wael El-Rifai; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

6.  Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy.

Authors:  Hu-Yang Xie; Yao Zhu; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen; Chao-Fu Wang; Hui-Zhi Zhang; Ding-Wei Ye
Journal:  Int Urol Nephrol       Date:  2012-09-01       Impact factor: 2.370

7.  Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer.

Authors:  Gang Li; Hualin Song; Jiaxin Wang; Yali Bao; Yuanjie Niu
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

8.  Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.

Authors:  Zhang-Song Wu; Wa Ding; Jiajia Cai; Ghassan Bashir; Yu-Qing Li; Song Wu
Journal:  Onco Targets Ther       Date:  2019-10-03       Impact factor: 4.147

9.  Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence.

Authors:  Fania S Doekhie; Hans Morreau; Geertruida H de Bock; Frank M Speetjens; N Geeske Dekker-Ensink; Hein Putter; Cornelis J H van de Velde; Rob A E M Tollenaar; Peter J K Kuppen
Journal:  Cancer Microenviron       Date:  2008-08-06

10.  MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.

Authors:  Hans Olsson; Per Hultman; Johan Rosell; Peter Söderkvist; Staffan Jahnson
Journal:  BMC Urol       Date:  2013-01-28       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.